Total Payments
$2,848
2024 Payments
$1,187
Companies
32
Transactions
161
Medicare Patients
1,103
Medicare Billing
$71,043
Payment Breakdown by Category
Food & Beverage$2,848 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,848 | 161 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $462.65 | 22 | $0 (2024) |
| Lilly USA, LLC | $408.45 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $302.60 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $212.09 | 11 | $0 (2024) |
| Novo Nordisk Inc | $183.58 | 11 | $0 (2024) |
| PFIZER INC. | $182.14 | 9 | $0 (2024) |
| Amgen Inc. | $162.08 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $122.44 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $118.41 | 8 | $0 (2024) |
| Exact Sciences Corporation | $96.69 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,187 | 64 | ABBVIE INC. ($254.29) |
| 2023 | $761.44 | 42 | Lilly USA, LLC ($163.26) |
| 2022 | $504.53 | 29 | AstraZeneca Pharmaceuticals LP ($71.94) |
| 2020 | $146.10 | 9 | Amarin Pharma Inc. ($21.04) |
| 2019 | $248.06 | 17 | AstraZeneca Pharmaceuticals LP ($77.29) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.99 | General |
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.02 | General |
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardio-renal | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Oncology | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: PAIN | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 48 | 77 | $14,064 | $5,290 |
| 2022 | 7 | 144 | 178 | $19,231 | $9,011 |
| 2021 | 13 | 424 | 1,426 | $65,982 | $33,222 |
| 2020 | 11 | 487 | 626 | $66,801 | $23,520 |
Total Patients
1,103
Total Services
2,307
Medicare Billing
$71,043
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 50 | $10,211 | $4,022 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 27 | $3,853 | $1,268 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 41 | $8,282 | $3,027 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $4,085 | $2,510 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 34 | $4,726 | $1,922 | 40.7% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 12 | 12 | $828.00 | $809.08 | 97.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $492.00 | $363.38 | 73.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 13 | 13 | $442.00 | $244.78 | 55.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 33 | 47 | $376.00 | $134.82 | 35.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 11 | 900 | $22,500 | $14,191 | 63.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 115 | $21,850 | $6,885 | 31.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 35 | 35 | $6,895 | $4,745 | 68.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 57 | $7,410 | $2,553 | 34.4% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 18 | 18 | $1,242 | $1,170 | 94.2% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 29 | 29 | $1,189 | $1,117 | 93.9% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 32 | 33 | $1,353 | $977.48 | 72.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 32 | 32 | $960.00 | $618.88 | 64.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $943.00 | $402.80 | 42.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 79 | 100 | $800.00 | $300.00 | 37.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 17 | $714.00 | $198.73 | 27.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 16 | 18 | $126.00 | $62.64 | 49.7% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 28 | 49 | $0.49 | $0.49 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 204 | $38,382 | $11,478 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 38 | 38 | $7,486 | $4,497 | 60.1% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 41 | 41 | $2,829 | $2,500 | 88.4% |
About Dr. Erin Morley, M.D
Dr. Erin Morley, M.D is a Family Medicine healthcare provider based in Greeley, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1639528045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erin Morley, M.D has received a total of $2,848 in payments from pharmaceutical and medical device companies, with $1,187 received in 2024. These payments were reported across 161 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,848).
As a Medicare-enrolled provider, Morley has provided services to 1,103 Medicare beneficiaries, totaling 2,307 services with total Medicare billing of $71,043. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Greeley, CO
- Active Since 06/07/2016
- Last Updated 04/01/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1639528045
Products in Payments
- VRAYLAR (Drug) $328.76
- MOUNJARO (Drug) $274.85
- FARXIGA (Drug) $127.20
- JARDIANCE (Drug) $122.35
- XIFAXAN (Drug) $118.41
- NURTEC ODT (Drug) $103.27
- Otezla (Drug) $100.75
- Cologuard Collection Kit (Device) $96.69
- SHINGRIX (Biological) $96.62
- Kerendia (Drug) $77.14
- Rybelsus (Drug) $74.87
- UBRELVY (Drug) $62.97
- COMIRNATY (Biological) $61.49
- AREXVY (Drug) $60.76
- Azstarys (Drug) $55.85
- QULIPTA (Drug) $53.83
- LEQVIO (Drug) $51.59
- Ozempic (Drug) $49.48
- Wegovy (Drug) $45.48
- ELIQUIS (Drug) $40.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greeley
Joy Ruff, M.d, M.D
Family Medicine — Payments: $44,700
Family Medicine $44,700
Dr. Chima Nwizu, Md, MD
Family Medicine — Payments: $6,387
Family Medicine $6,387
Dr. Gregory Denzel, Do, DO
Family Medicine — Payments: $5,085
Family Medicine $5,085
Dr. Donald Wilson, Md, MD
Family Medicine — Payments: $4,831
Family Medicine $4,831
Dr. Robert Haskins, Md, MD
Family Medicine — Payments: $3,179
Family Medicine $3,179
Kyle Waugh, Md, MD
Family Medicine — Payments: $3,127
Family Medicine $3,127